NCT01270087View on ClinicalTrials.gov

The Effect of Adalimumab (Humira) on Vascular Abnormalities in Rheumatoid Arthritis. A Pilot Study.

PHASE4CompletedINTERVENTIONAL
Enrollment

14

Participants

Timeline

Start Date

May 31, 2005

Primary Completion Date

February 28, 2007

Study Completion Date

February 28, 2007

Conditions
Rheumatoid Arthritis
Interventions
DRUG

Adalimumab

40 mg IV every 14 days

Trial Locations (1)

205 02

Department of Rheumatology, Skåne University Hospital, Malmo

Sponsors

Collaborators (1)

Abbott
All Listed Sponsors
collaborator

Abbott

INDUSTRY

collaborator

The Swedish Research Council

OTHER_GOV

collaborator

The Swedish Rheumatism Ass

OTHER

collaborator

Crafoord Foundation

OTHER

lead

Skane University Hospital

OTHER